Alaunos Therapeutics | ZIOP - Ativos





Ativos Alterar Data
Alaunos Therapeutics USD 2.97M 758K 2025-12
Amgen USD 92.5B 1.92B 2026-03
AstraZeneca USD 114.02B 59M 2026-03
Baxter International USD 19.85B 209M 2026-03
Biogen USD 29.48B 43.6M 2026-03
Bioline Rx USD 39.8M 3.47M 2025-09
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
Celltrion KRW 21.08T 530.63B 2025-09
Corcept Therapeutics USD 814.88M 21.77M 2026-03
Cspc Pharmaceutical CNY 46.7B 695.56M 2025-12
Curis USD 19.97M 9.27M 2025-12
Deva Holding AS TRY 12.93B 1.83B 2023-09
Dianthus Therapeutics USD 530.92M 46.52M 2025-12
Divis Laboratories Ltd INR 181.51B 12.19B 2025-09
Gilead Sciences USD 59.02B 490M 2025-12
GlaxoSmithKline GBP 62.87B 1.75B 2026-03
Incyte USD 7.34B 381.14M 2026-03
Intrexon USD 73.16M 77.88M 2024-06
Ionis Pharmaceuticals USD 3.45B 74M 2026-03
J&J USD 200.89B 1.68B 2026-03
Kangmei Pharma CNY 13.68B 38.19M 2025-09
Karyopharm Therapeutics USD 108.42M 12.18M 2025-12
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Malin Corporation EUR 198.5M 70.1M 2024-12
Medical Developments International AUD 63.57M 2.83M 2025-12
Merck USD 136.87B 7.32B 2025-12
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
Novartis USD 110.95B 3.66B 2025-12
Organigram Holdings CAD 530.67M 31.54M 2025-12
Ovoca Bio EUR 1.66M 9.75M 2025-06
Pfizer USD 208.73B 2.64B 2025-09
Pharma Mar EUR 395.08M 53.42M 2025-12
PTC Therapeutics USD 2.9B 255.07M 2025-12
Qiagen NV USD 6.3B 257.54M 2025-12
Regeneron Pharmaceuticals USD 40.87B 310.1M 2026-03
Roche Holding CHF 100.7B 5.94B 2025-12
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sartorius EUR 9.87B 154.9M 2026-03
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
TG Therapeutics USD 1.06B 38.23M 2025-12
Tilray USD 2.1B 15.95M 2025-09
Verastem USD 246.44M 69.59M 2025-12
Zealand Pharma A/S 15.95B 848.45M 2025-12
Zz Pientze Pharmaceu CNY 18.38B 905.93M 2026-03